Ann Surg Oncol

1. KWON H, Park SY
   Single-Port Robotic Cytoreductive Surgery for Colon Cancer Peritoneal Recurrence with the da Vinci SP.
   Ann Surg Oncol. 2026 Jun 19. doi: 10.1245/s10434-026-19743.
   

   >> Share

   
   
2. CHANG JG, Park IJ, Kim YI, Lee JL, et al
   Predominance of Peritoneal Metastasis in the Recurrence Pattern of T4 Colorectal Cancer: A Retrospective Cohort Study.
   Ann Surg Oncol. 2026 Jun 14. doi: 10.1245/s10434-026-19933.
   

   >> Share

   
   
3. SIMON EF, Erozkan K, Westfall KM, Khan SZ, et al
   Association Between Clinical Tumor Stage and Response to Total Neoadjuvant Therapy in Rectal Cancer: Outcomes in cT3 Versus cT4 Disease.
   Ann Surg Oncol. 2026;33:6521-6529.
   

   >> Share

   
   
4. SONG Y, Seier K, Chandra P, Shia J, et al
   The Margin of the Largest Tumor Predicts Overall Survival After Resection of Multitumor Colorectal Liver Metastases.
   Ann Surg Oncol. 2026;33:6030-6040.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. YE L, Hou QL, Peng H, Yang Q, et al
   One- versus two-sample fecal immunochemical testing for colorectal cancer screening: a systematic review and meta-analysis of participation, diagnostic performance, and cost-effectiveness.
   BMC Gastroenterol. 2026 Jun 16. doi: 10.1186/s12876-026-04954.
   

   >> Share

   
   
6. CHEN Y, Gao X, Wang L, Zhang C, et al
   Colorectal adenoma recurrence: an analysis of risk factors and gut microbiota characteristics.
   BMC Gastroenterol. 2026;26:363.
   

   >> Share

   
   

   
   Br J Cancer

7. BYRD DA, Zouiouich S, Wahl D, Pardini B, et al
   Fecal immunochemical tests from population-based colorectal cancer screening programs support prospective microbiome cohorts.
   Br J Cancer. 2026 Jun 12. doi: 10.1038/s41416-026-03495.
   

   >> Share

   
   
8. STEPANYAN A, Kotsafti A, Rosato A, Castagliuolo I, et al
   Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic review.
   Br J Cancer. 2026;135:139-151.
   

   >> Share

   
   

   
   Br J Surg

9. TEJEDOR P, Pastor C, Santos ST, Rodriguez Y, et al
   Clinical and Molecular Heterogeneity of Metachronous Colorectal Cancer.
   Br J Surg. 2026 Jun 16:znag078. doi: 10.1093.
   

   >> Share

   
   
10. PAN S, Wang G
    Preoperative multisystem circadian coupling and long-term outcomes after colorectal cancer surgery.
    Br J Surg. 2026 Jun 16:znag073. doi: 10.1093.
    

    >> Share

    
    

    
    Cancer Lett

11. ZHOU Y, Yu JH, Sui QQ, Liao LE, et al
    POSTN(+) cancer-associated fibroblasts forming fortress-like barrier to mediate immunotherapy resistance in colorectal cancer.
    Cancer Lett. 2026 Jun 17:218683. doi: 10.1016/j.canlet.2026.218683.
    

    >> Share

    
    
12. GOBERT AP, Hawkins CV, Asim M, Barry DP, et al
    Regulation of EIF5A and hypusination by p53 determines colorectal cancer cell fitness.
    Cancer Lett. 2026 Jun 15:218682. doi: 10.1016/j.canlet.2026.218682.
    

    >> Share

    
    
13. ZHANG S, Xu K, Du Y, Liu Z, et al
    Corrigendum to "Cross-species single-cell and spatial transcriptomic mapping reveals EFNA1-EPHA4-mediated stem-like epithelial-macrophage crosstalk driving colorectal cancer progression" [Cancer Letters 649 (2026) 218495].
    Cancer Lett. 2026 Jun 12:218672. doi: 10.1016/j.canlet.2026.218672.
    

    >> Share

    
    

    
    Dis Colon Rectum

14. OH SY, Lee J, Han K, Ku GY, et al
    Risk of Metabolic Disease After Right- vs Left-Sided Colectomy for Colon Cancer: A Nationwide Cohort Study.
    Dis Colon Rectum. 2026 Jun 19. doi: 10.1097/DCR.0000000000004350.
    

    >> Share

    
    
15. HUANG Y, Schultz KS, D'Aquila ML, Thomson Blake KB, et al
    Patient-Level Socioecological Comorbidities and Time to Initiation of Curative-Intent Treatment for Colorectal Cancer.
    Dis Colon Rectum. 2026 Jun 15. doi: 10.1097/DCR.0000000000004330.
    

    >> Share

    
    

    
    Eur J Surg Oncol

16. DE ROO AC, Neuman HB
    Navigating the complexities of rectal cancer management: Shared decision-making and patient perspectives in critical choices.
    Eur J Surg Oncol. 2026;52:111738.
    

    >> Share

    
    
17. WILLIAMS A, Woods F, O'Neill C, Hutchings H, et al
    Using agile development methodology to develop a decision aid for complex rectal cancer.
    Eur J Surg Oncol. 2026;52:111813.
    

    >> Share

    
    
18. PENEL N, Toulmonde M, Wallet J, LE Cesne A, et al
    Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.
    Eur J Surg Oncol. 2026;52:111903.
    

    >> Share

    
    
19. REESE T, Engstrand J, Bjork D, Ottestad AM, et al
    Propensity matched comparison between one-stage and two-stage hepatectomy after portal vein embolization for bilateral colorectal liver metastases.
    Eur J Surg Oncol. 2026;52:111884.
    

    >> Share

    
    
20. RAFII S, Mukherji D, Chamseddine AN, Al-Shamsi HO, et al
    Immunotherapy and surgical decision-making in Lynch syndrome-associated colorectal cancer: Implications for personalized management and guideline revision.
    Eur J Surg Oncol. 2026;52:111948.
    

    >> Share

    
    

    
    Gastrointest Endosc

21. XU X, Jin Y
    Rectal location and recurrence after resection of high-risk T1 colorectal cancer.
    Gastrointest Endosc. 2026;104:136-137.
    

    >> Share

    
    
22. GWEON TG, Kim SJ, Myung DS, Jung Y, et al
    Optimal endoscopic treatment for rectal neuroendocrine tumors, confirmed after forceps biopsy: a Korean Association for the Study of Intestinal Diseases multicenter, randomized noninferiority trial.
    Gastrointest Endosc. 2026;104:86-94.
    

    >> Share

    
    
23. FANTASIA S, Kayali S, Cortegoso Valdivia P, Andreotti S, et al
    Superiority of excellent over good bowel preparation for proximal serrated polyp detection in a fecal immunochemical test-based screening cohort.
    Gastrointest Endosc. 2026;104:69-76.
    

    >> Share

    
    

    
    Gut

24. WANG J, Zhou M, Tan B, Shi H, et al
    SPP1(+) macrophages facilitate the differentiation and maturation of regulatory T cells in tumour-draining lymph nodes of colorectal cancer.
    Gut. 2026 Jun 12:gutjnl-2025-337038. doi: 10.1136/gutjnl-2025-337038.
    

    >> Share

    
    
25. PALLES C, Freeman-Mills L, Arbe-Barnes E, Feeley N, et al
    Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis.
    Gut. 2026;75:1353-1366.
    

    >> Share

    
    
26. HOU Y, Wu H, Zhang Z, Wang J, et al
    Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites.
    Gut. 2026;75:1322-1337.
    

    >> Share

    
    

    
    Int J Cancer

27. YANG G, Milne GL, Nogueira MS, Gao YT, et al
    Systemic Lipid Peroxidation and Colorectal Cancer Risk: A Time-Varying Relationship.
    Int J Cancer. 2026 Jun 15. doi: 10.1002/ijc.70585.
    

    >> Share

    
    

    
    Int J Colorectal Dis

28. USUI A, Kobayashi H, Kotake K, Maeda K, et al
    Evaluation of the prognostic impact of intraoperative cytology results according to tumor sidedness in stage II/III resectable colorectal cancer.
    Int J Colorectal Dis. 2026 Jun 15. doi: 10.1007/s00384-026-05173.
    

    >> Share

    
    
29. BULUT M, Knuhtsen S, Eriksen JR, Bremholm L, et al
    Multidisciplinary team-guided combined endoscopic laparoscopic surgery for complex colonic lesions: a single-center retrospective cohort study.
    Int J Colorectal Dis. 2026;41:100.
    

    >> Share

    
    

    
    J Clin Oncol

30. SHARMA MR, Powderly J, Kuboki Y, Strickler JH, et al
    Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.
    J Clin Oncol. 2026 Jun 15:JCO2601401. doi: 10.1200/JCO-26-01401.
    

    >> Share

    
    

    
    J Pathol

31. KEHUSMAA A, Harkonen J, Li H, Sirnio P, et al
    Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.
    J Pathol. 2026 Jun 18. doi: 10.1002/path.70087.
    

    >> Share

    
    

    
    J Surg Oncol

32. LOCKHORST EW, Backhuijs TAM, Kerkhoff TME, van den Braak RRJC, et al
    Prehabilitation Prior to Colorectal Cancer Surgery: Impact and Implementation.
    J Surg Oncol. 2026 Jun 18. doi: 10.1002/jso.70305.
    

    >> Share

    
    
33. MYERS S, Davis ES, Ng SC, Sachs T, et al
    Distance to Care, Regional Context, and Survival in Early-Onset Colorectal Cancer.
    J Surg Oncol. 2026 Jun 15. doi: 10.1002/jso.70307.
    

    >> Share

    
    

    
    Oncogene

34. KONECNY T, Zadirako N, Grigoryan A, Tamazyan M, et al
    Transcriptomic profiling identifies immunotherapy-responsive phenotypes in microsatellite-stable metastatic colorectal cancer.
    Oncogene. 2026 Jun 16. doi: 10.1038/s41388-026-03861.
    

    >> Share

    
    
35. PARK SJ, Lee SW, Moon H, Jung SM, et al
    Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability.
    Oncogene. 2026 Jun 15. doi: 10.1038/s41388-026-03850.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share